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After intraperitoneal injection of mice with Escherichia coli strains isolated 
from patients with urinary tract infections, the mortality due to hemolytic (Hly+) 
and nonhemolytic (Hiy-) isolates was 77 and 40%, respectively. Deletion of the 
chromosomal hemolysin (h/y) determinant in an E. co/i 06:K15:H31 urinary tract 
infection strain led to a significant reduction in toxicity for mice, and its 
reintroduction on a recombinant plasmid partially restored the original toxicity. 
Although introduction of the cloned plasmid pHiy152-encoded hly determinant 
into the Hly- E. coli 06 mutant strain increased toxicity by only a marginal 
degree, transformation with the cloned chromosomal hly determinants from two 
E. coli strains of serotypes 018ac:K5:H- and 075:K95:H? resulted in markedly 
greater toxicity, even exceeding that of the original Hly+ E. coli 06 wild-type 
strain. 
Hemolytic (Hiy+) Escherichia coli strains 
may be isolated from a variety of sources. In 
humans, a low percentage (up to 12%) of the 
normal fecal E. co/i strains are Hly+ (16, 18) 
compared with 35 to 50% of E. coli strains 
causing extraintestinal infections, such as bac-
teremia, septicemia, and urinary tract infections 
(UTI) (17, 23). 
Hly+ E. coli strains isolated from humans 
usually carry the hly determinant on the chromo-
some (18, 19, 24; D. Müller, J. Hacker, and C. 
Hughes, unpublished results), whereas earlier 
reports examining Hly+ E. coli strains from 
animal sources bad shown that the genes for 
hemolysin formation are located on large trans-
missible plasmids (4, 12, 29, 33). The plasmid 
and chromosomal hly determinants share high 
sequence homology (4, 24), and all comprise 
four genes involved in the synthesis ofthe active · 
hemolysin (hlyA and hlyC) and its transport 
(hlyBa and hlyBb) (11, 25, 26, 38). 
Among E. coli strains causing UTI, the pro-
duction of hemolysin is often associated with 
other factors assumed to contribute to virulence, 
i.e., mannose-resistant hemagglutination (Mrh+) 
caused by specific protein pili (7) and specific 0-
and K-antigens (14, 27, 28). These additional 
factors cause adherence of the bacteria to epi-
thelial cells and resistance to serum and phago-
cytosis (20, 31, 32). The frequent occurrence of 
the Hly+ phenotype among these E. coli strains 
suggests that hemolysin may also contribute to 
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virulence in extraintestinal E. coli infections, 
and investigations with Hly + and nonhemolytic 
(Hiy-) E. coli strains in different animal models 
(5, 8-10, 22, 23, 34-37) and cell cultures (3) seem 
to support this view. In most cases, however, 
data have been obtained from clinical studies or 
with strains mutagenized in an uncontrolled way 
or differing by the presence or absence of Hly 
plasmids of more than 60 kilobases (kb). Welch 
et al. (39) first demonstrated the direct contribu-
tion of hemolysin to E. coli virulence by cloning 
the chromosomal region containing the hly de-
terminant and measuring its inftuence in a rat 
peritonitis model. 
In this paper we first present epidemiological 
and genetic data to emphasize the association of 
hly carriage with higher Ievels of toxicity for 
mice among E. coli causing UTI. We then dem-
oostrate the causal relationship by exact isola-
tion of chromosomal hly genes from strains of 
the predominant UTI serotypes 06, 018ac, and 
075. In addition, we show that these precisely 
subcloned determinants, which have small dif-
ferences in hlyA, encode Ievels of toxicity mark-
edly different to each other and to that coded for 
by a cloned plasmid hly determinant. 
MATERIALS AND METHODS 
E. coU wild-type strains. The 69 E. coli strains tested 
for toxicity were isolated froril patients attending the 
UTI clinic at Charing Cross Hospital, London, En-
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gland and were identified by standard methods. Addi-
tional characterization of the strains, i.e., hemolysin 
synthesis, colicin V production (Cva +), and the car-
riage of K-, 0-, and hemagglutination (HA)-antigens 
have been described previously (17). Strains from 
which hly + clones were derived are listed in Table 1. 
Mutants, transformants, and recombinant DNAs. E. 
coli strain 536, isolated from a patient suffering from 
UTI, was obtained from the Institut für Hygiene und 
Mikrobiologie, Universität Würzburg, Germany. This 
strain belongs to the serotype 06:K15:H31 and is Mrh 
Vb (causing mannose-resistant hemagglutination of 
bovine erythrocytes and a delayed HA with human 
and guinea pig erythrocytes). 
The spontaneaus mutant Nr.21 of strain 536 has 
been described elsewhere and has lost the ability to 
produce hemolysin and the Mrh+ phenotype (Hly-, 
Mrh-) owing to a deletion in the chromosome of more 
than 30 kb (15; S. Knapp, personal communication). 
Strain 536/21 was transformed with hly+ re-combinant 
plasmids by a modified CaCI:! procedure for wild-type 
strains (21) grown in Luria broth. In all cases, these 
recombinant DNAs contain BamHI-Sa/1 fragments 
carrying hlyA, hlyB8 , and hlyBb of various chromo-
somal and plasmid hly determinants cloned into 
pANN202, which is pACYC184 bearing hlyC of the 
plasmid pHiy152 (Table 1) (1, 11, 25). The construc-
tion of these recombinant plasmids is summarized in 
Fig. 1. . 
Isolation of plasmid DNA. Plasmid DNA from trans-
formants carrying recombinant DNA was screened by 
the cleared lysate procedure (2). Preparative DNA 
isolationwas achieved as described previously (13). 
Toxicity tests. The toxicity of bacteria for mice was 
assessed by a modification of the test described by 
Van den Bosch et al. (36). Cells from ovemight 
cultures (grown in enriched nutrient broth) were har-
vested, washed twice in phosphate-buffered sali11e, 
and suspended in phosphate-buffered saline to ca. 109 
viable cells per ml. Ten female specific-pathogen-free 
NRMI mice (each weighing ca. 16 g; Zentral-Institut 
TABLE 1. Recombinant plasmids 
Recombinant Cloned hly genes Reference plasmid 
pANN202 hlyC from pHiy152a (25) 
pANN202-312 hlyC, hlyA, hlyB8 , and (11) 
hlyBb from 
pHiy152a 
pANN5211-06 hlyC from pHly152,a (1) 
hlyA, hlyB8 , and 
hlyBb from E. coli 
S36b (06:K15:K31) 
pANN5311-018ac hlyC from pHly152,a (1) 
hlyA, hlyB8 , and 
hlyBb from E. coli 
764b (018ac:K5:H-) 
pANN5411-075 hlyC from pHly152,0 (1) 
hlyA, h/yB8 , and 
hlyBb from E. coli 
341b (075:K95:H?) 
a Plasmid-bome genes. 
b Chromosomal genes. 
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für Versuchstiere, Hannover, Germany) were injected 
via the intraperitoneal route with 0.2 ml of the suspen-
sion described above. The number of mice killed after 
24 h was recorded. The toxicity of the E. coli 06 wild-
type strain 536, the E. coli 06 deletion mutant 536/21, 
and the transformed strains carrying the recombinant 
plasmids was quantified by injecting 7 x 107 to 8 x 108 
E. coli cells into the mouse peritoneal cavity. In all 
toxicity tests, at least 10 mice were used per strain. To 
test whether multiplication of the bacteria occurred, 
the spleens of several killed mice were removed and 
homogenized, and viable bacteria were counted. The 
properlies of the reisolated bacteria were controlled by 
examining 100 colanies of each strain. Strains 536 and 
536/21 were tested with endotoxin-resistant C3H/He 
mice (Zentral-Institut für Versuchstiere). 
Screening of transformants and strains reisolated 
from mice. Transformed strains and those isolated 
from the spleens of dead or surviving mice were 
checked for the presence of covalently closed circular 
DNA and markers on the recombinant DNA (chloram-
phenicol resistance and hemolysin production). The 
536/21 derivatives were further tested for chromo-
somal Streptomycin resistance and production of K15-
and 06-antigens. 
The K15-antigens were detected by slide agglutina-
tion with K15 antiserum (kindly provided by G. 
Schmidt, Max-Planck-Institut für Immunobiologie, 
Freiburg, Germany). 06 antiborlies were raised 
against an 06 Standard strain (kindly provided by I. 
0rskov and F. 0rskov, Statens Ser\rminstitut, Copen-
hagen, Denmark), and dilutions were used to assay the 
06 titer of strain 536 and its derivatives. In each case 
the standard strain was used as a control (16). 
RESULTS 
Toxicity of Hly+ and Hly- E. coli strains 
causing UTI. We assessed the toxicity of clinical 
isolates in a mouse mortality test, i.e., the ability 
of high doses of living bacteria to kill mice 
without extensive multiplication. In our experi-
ments, the mice did not die from an E. · coli 
infection but rather from toxicity. The mice died 
6 to 20 h after injection of the bacteria without 
extensive multiplication. From an inoculum of 
more than 108 bacteria, only 105 to 104 and 103 to 
102 bacteria could be isolated after 3 and 24 h, 
respectively, from the spleens of dead and sur-
viving animals. 
Of the 69 E. coli UTI strains tested, 46 were 
derived from symptomatic infections, and 23 
were derived from asymptomatic infections (17). 
Of the Hly+ strains, 90% killed 6 or more of 10 
mice within 24 h comp~ed with 35% ofthe Hly-
isolates (Fig. 2). In all cases in which no (or only 
one or two) mice were killed, the test strain was 
Hly-. The difference between the mean number 
of deaths caused by Hly+ and Hly- strains, 7.7 
and 4.0 (10 mice tested), respectively, was sig-
nificant (x2, 89.3 and P < 0.01), and the standard 
deviations ofthe means, 2.0 and 3.9, respective-
ly, are a measure of the constant toxicity Ievels 
determined by Hly+ strains and of the relatively 
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FIG. 1. Construction of the recombinant DNAs. The open boxes indicate chromosomally encoded hly 
cistrons, the hatched boxes indicate plasmid-encoded hly cistrons, and the broken lines indicate the 2-kb DNA 
segments between the distal ends of hlyBb and the San sites, which encode no gene products (see text). 
heterogeneaus degree of toxicity associated with 
their Hly- Counterparts. Within the different 0 
serogroups, the Hly+ strains were more toxic 
than the Hly- strains. Higher toxicity for mice 
seems tobe independent of the HA-, Kl-, and 
K5-antigens and colicin V production. These 
findings support the view that hemolysin exerts 
a toxic effect. To analyze this hypothesis fur-
ther, genetic manipulation of hly determinants 
was undertaken. 
Toxlcity of Hly+ E. coü 536 (06) and spontane-
ous Hly- deletion mutants. As described else-
where (15), the hemolytic E. coli strain 536, 
which carries a chromosomal hly determinant, 
gives rise to nonhemolytic mutants at a frequen-
cy of 10-3 to 10-4• From hybridization studies, it 
is clear that all mutants tested, including mutant 
536/21 used here, result from deletions in the 
region containing hly and the determinant which 
codes for mannose-resistant hemagglutination 
(mrli). The toxicity of the Hly+ wild-type strain 
536 and that of the Hly- mutant 536/21 were 
compared, and sirain 536 killed 30% of the 
NMRI mice at titers of 7 x 107 with a 100% 
Iethai dose of 5 x 108 (Fig. 3). The toxicity ofthe 
deletion mutant 536/21, which still retains the 
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FIG. 2. Toxicity for mice of E. coli strains causing symptomatic and asymptomatic UTI in relation to 
hemolysin production and other presumptive virulence factors. The closed symbols represent Hty+ strains, and 
the open symbols represent Hly- strains. Symbols: V, colicin V production; 1, K1-antigen; 5, K5-antigen; • and 
0, Mrh+; ~ and 'iJ, mannose-sensitive HA (Msh+) and HA type 111, not common type I; e and 0, no HA (HA 
type IVb). 
K15-antigen and shows the same 06-antigen 
titer as the wild-type parent, dropped considera-
bly. A titer of8 x 108 bacteria killed only 45% of 
the NMRI mice, and no mice were killed at titers 
between 7 x 107 and 8 x 108• Analogous results 
were obtained when C3H/He endotoxin-resis-
tant mice were used. At titers of 107 and 108 
bacteria, no mice and 80% of the mice, respec-
tively, were killed by the Hly+ wild-type isolate 
536. At both titers, no mice died after injection 
of the Hly- 536/21 derivative. At titers of 109 
bacteria all C3H/He mice were killed by both 
strains. Further tests were carried out with 
NMRI mice. The deletion mutant 536/21 was 
used for further analysis, as it provided an 
extremely suitable system to study the effects of 
isolated hly genes. 
Toxicity of the Hly- E. coli 536/21 (06) mutant 
carrying cloned hly determinants. By using the 
cosmid system, chromosomal hly determinants 
were isolated (1) from E. coli strains betonging 
to three serogroups (06, 018ac, and 075) pre-
dominant and typically Hly+ in UTI (17). The 
determinants, first isolated on the cosmid clones 
pANN 521-06, pANN531-018ac, and 
pANN541-075 (see Fig. 1), were then subcloned 
in such a way that the effects on toxicity and 
virulence of the hemolysins produced could be 
assessed and compared directly, i.e., by mini-
mizing the presence of nonh/y DNA. This was 
done by introducing BamHl-Safl fragments car-
rying hlyA, hlyBa, and hlyBb, which encode 
synthesis of the hly precursor and transport of 
the processed product out of the cell, into the 
100 
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FIG. 3. Toxicity for mice ofthe Hty+ E. co/i wild-type strain (06:K15:H31), the Hly- deletion mutant 536/21, 
and 536/21 transformed with the plasmid pANN202. 
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clone pANN202. pANN202 is the vector 
pACYCt84 carrying hlyC (from the plasmid 
pHlyt52), which is responsible for processing of 
the precursor (24, 25; M. Härtlein, S. Schiessl, 
U. Rdest, J. Kreft, and W. Goebel, submitted 
for publication). The hly determinant of the 
plasmid pHlyt52 was cloned in the same way; 
therefore, the four hlv determinants examined 
are directly comparabie. 
As a preliminary test, the common vector 
pANN202 (pACYCt83:h/yC) was transformed 
into E. coli 536/2t, and the toxicity of the Hly-
mutant was unaltered (Fig. 3). This was plainly 
not the case, however, after introduction of the 
four hly+ recombinant DNAs, as all increased 
the toxicity ofthe Hly- deletion mutant (Fig. 4). 
Furthermore, the resulting leveis of toxicity 
were significantly different. The plasmid-bome 
hly determinant (pANN202-3t2) contri~uted 
only marginally to toxicity; i.e., at a dose of 2.5 
x tos, only 7% of the mice were killed, and the 
50% Iethai dose was 8 x tos. The lowest contri-
bution to toxicity of the chromosomal hly deter-
minants was observed with that of E. coli 06 
(pANN5211-06). Titers of2.5 x tos and 5 x tos 
killed 30 and 70% of the mice, respectively. 
In contrast, the 536/2t mutant carrying the hly 
determinants from the strains Ot8ac 
(pANN5311-0t8ac) and 075 (pANN5411-075) 
killed 90 and tOO% ofthe mice, respectively, at a 
titer of 2.5 x tos. The 50% Iethai dose of the 
nontransformed strain 536/2t was ca. 8 x tos. 
After introduction of the cloned hly determi-
nants from E. coli 764 (Ot8ac:K5:H-) and E. 
coli 341 (075:K95:H?), the 50% Iethai dose 
dropped to ca. 7 x 107 ; i.e., the hly determinants 
increased the toxicity of the strains by a factor of 
ten. lnterestingly, after introduction of both the 
018ac and the 075 hly determinants the 536/21 
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strain showed a higher toxicity than wild-type 
parent strain 536 (Fig. 3 and 4). All strains 
isolated after 24 h still had Streptomycin resist-
ance; the K15-antigen, and the same 06-antigen 
titer. The endotoxin thus appears to have no 
inftuence on the change in toxicity measured in 
this test. A total of 90% or more of the strains 
still carried the recombinant plasmid DNA, as 
indicated by the retention of chloramphenicol 
resistance (Cml) and Hly+ markers and also by 
gel electrophoresis of cleared cell lysates. 
Strains which bad lost the recombinant hly + 
DNAs but still retained the 06-antigen (and also 
the Kt5-antigen) showed the same Ievel of toxic-
ity as the original 536/21 mutant strain (data not 
shown). As described for the urinary tract iso-
lates, no extensive multiplication of the strains 
could be observed. From an inoculum of more 
than tos bacteria only to-s to to-4 bacteria were 
isolated from spleens after t h, and this titer 
decreased to 10-3 to to-2 after 24 h. These data 
strongly suggest that the increased toxicity is 
determined by the cloned hly cistrons. 
DISCUSSION 
Among the E. coli strains causing extraintes-
tinal infections, hemolysin production is espe-
cially common (6, t7, 23) and is associated with 
higher Ievels of toxicity for mice after intraperi-
toneal injection. The view that it contributes to 
E. coli virulence in such infections, e.g., those of 
the urinary tract, is supported by the use of in 
vivo models (3, 5, 8-tO, 23, 36, 37). Data from 
stu~ies on clinical isolates or genetic variants of 
bacterial strains which have been mutagenized 
or have lost or received large plasmids (8, 9, 22, 
23, 34-37) are, nevertheless, indicative rather 
than conclusive. The genetic background of the 
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FIG. 4. Inftuence of the transformed cloned hly determinants on the toxicity for mice of the Hly- E. coli 
deletion mutant 536/21. · 
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organisms examined, particularly the immediate 
environment of the hly determinants involved, 
is, to various degrees, undefined, and as the 
extraintestinal pathogenesis of E. coli strains 
appears to be a multifactorial phenomenon (7, 
17, 23), the specific contribution of hemolysin 
itself cannot be readily deduced. 
The one previous use of recombinant DNA 
techniques to resolve this problern compared 
virulence in a rat peritonitis model of an E. coli 
fecal strain after introduction of recombinant 
DNAs carrying chromosomal (pSF4000) (39) 
and plasmid (pANN202-312) (described above 
and in reference 11) hly determinants cloned into 
pACYC184. The size of the chromosomal insert 
found to increase virulence, 11.7 kb, was twice 
that required for hemolysin synthesis (11, 25), 
and the additional DNA was uncharacterized. 
Since we have observed that chromosomal hly 
determinants may be located in the vicinity of 
genes encoding HA (15) and serum resistance 
(C. Hughes, J. Hacker, S. Knapp, and W. 
Goebel, manuscript in preparation), factors as-
sumed to inftuence urinary tract virulence (31, 
32), our primary aim was to study the effects of 
precisely defined hly+ recombinant DNAs de-
rived from different serotypes in a well-charac-
terized genetic background. This was made pos-
sible by the use of the well-defined UTI 06 
derivative strain 536/21 and the cloning strategy 
described above. 
The endotoxin appears to have no inftuence 
on the change in toxicity for mice because all 
derivatives of the 536/21 strain tested showed 
the same amount of 06-antigen as did the wild-
type parent. When the 536 Hly+ wild-type strain 
and the 536/21 Hly- mutant were injected, the 
same results were found with endotoxin-resis-
tant and -sensitive mice. Strains cured of hemo-
lysin production but still retaining the 06-anti-
gen lost the ability to increase toxicity for mice. 
The cloning of the various hly determinants 
was achieved by subcloning BamHI-Sa/1 frag-
ments known (1, 11) to carry the hlyA, hlyB3 , 
and hlyBb cistrons of hly determinants into the 
vector pACYC184 carrying hlyC (pANN202) 
(Fig. 1). This resulted in the foreign DNA being 
restricted almost exclusively to the hly determi-
nant and its normal regulatory regions. There is 
virtually no additional DNA between the N-
terminal (h/yC) end and pACYC184. Approxi-
mately 2 kb of chromosomal DNA, known from 
Southem blots to have no homology with hly 
and mrh genes (S. Knapp, personal communica-
tion) and to encode no gene products in either 
mini- or maxicells, is located at the C-terminal 
end distal to hlyBb (Härtlein et al., submitted for 
publication). 
These recombinant DNAs determined an in-
crease in the toxicity of an Hly- mutant of an 06 
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UTI isolate which Iacks its mrh and hly genes 
owing to a well-characterized chromosomal de-
letion (15). Since pANN202 does not inftuence 
toxicity' the toxic effects must be assumed to 
derive from the gene products of the BamHI-
Sall fragments. It has been shown by comple-
mentation tests (Müller, D., J. Hacker, and W. 
Goebel, manuscript in preparation) that the 
transport functions of the different hly determi-
nants tested are structurally and functionally 
closely related, if not identical. Despite the fact 
that the cloned hly determinants are located on 
multicopy plasmids, the Ievel of the secreted 
hemolysins is the same as that in the wild-type 
strains from which the hly determinants were 
derived (1, 11, 26, 30). These findings indicate 
that the different contributions to toxicity do not 
result from quantitative differences in the 
expression or the transport of the cistrons hlyBa 
and hlyBb. Rather, it seems likely that the small 
variations previously observed in the nucleotide 
sequence of the hlyA cistrons of these four 
recombinant DNAs (1) inftuence in a marked 
manner the toxicity of the resulting hemolysin 
proteins, presumably by involving changes in 
either overall conformation or in an as yet 
undetermined active site. Thus, although hemo-
lysin production may be regarded as a marker of 
UTI virulence among E. coli (17), the phenotype 
may not indicate a constant Ievel of toxicity. 
Such small differences in structure have already 
been noted among E. coli toxins produced dur-
ing intestinal infections (40). 
To avoid the term "virulence" in connection 
with our results we refer to "toxicity" ip de-
scribing the reduction in the Iethai dose for mice 
caused by the hly determinants. The virulence of 
uropathogenic strains comprises the properties 
of adherence, multiplication, and interference 
with the host defense system. After attachment 
and colonization, the toxic or cytotoxic potential 
of the bacteria may be essential for the progres-
sion of UTI, e.g., by damaging kidney cells or 
destroying leukocytes (3, 9, 10). The existence 
of defined hly+ recombinant DNAs derived from 
strains of different Serotypes should now allow a 
more precise appraisal of the specific action of 
hemolysin in the development of UTI. 
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